|
Back to Home » November 2022 News » Preliminary Results from Two Clinical Studies of Selinexor to be Presented at 2022 ASH Annual Meeting |
Preliminary Results from Two Clinical Studies of Selinexor to be Presented at 2022 ASH Annual Meeting |
November 07, 2022
- Poster with updated Phase Ib TOUCH results suggest selinexor plus GemOx could provide a therapeutic option for heavily pre-treated Stage III/IV patients with relapsed/refractory (R/R) T and NK-cell lymphoma - Online abstract with results from the open-label LAUNCH study demonstrated the...
Source URL: http://prnmedia.prnewswire.com/news-releases/preliminary-results-from-two-clinical-studies-of-selinexor-to-be-presented-at-2022-ash-annual-meeting-301669857.html
|
|
|
|
